Obesity News and Research

Latest Obesity News and Research

Families who ate together more often during the pandemic had more positive interactions

A study reveals that increased family dinner frequency during COVID-19 positively impacts mental health and social interactions in children and adults.

31 Oct 2024

Semaglutide reduces urine albumin-to-creatinine ratio in overweight chronic kidney disease patients

Researchers investigate the clinical efficacy of semaglutide in controlling urine albumin-to-creatinine ratio in overweight patients with chronic kidney disease.

31 Oct 2024

Study links ketogenic diet to improved menstrual health

Increasing ketones in the blood through a keto diet or supplements may help put irregular menstrual cycles back on schedule or even restart a period that appears to have stalled for good, new research suggests.

30 Oct 2024

For kids and teens, extra weight could mean a higher chance of long COVID

The study reveals a dose-response relationship between BMI and PASC risk in children, highlighting obesity as a key factor in post-COVID health challenges.

30 Oct 2024

Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients

Nirmatrelvir-ritonavir effectively lowers hospitalization rates and long COVID symptoms in non-hospitalized, high-risk patients with mild to moderate COVID-19.

30 Oct 2024

Survey reveals lack of awareness about pancreatic cancer risk among adults under age 50

While pancreatic cancer rates are rising in people under age 50, a new survey conducted by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) shows most people continue to believe that pancreatic disease affects only the elderly – and that there is nothing they can do to reduce their risk.

30 Oct 2024

Higher zinc intake linked to increased endometriosis risk, study finds

Researchers explore the association between zinc intake and endometriosis risk.

30 Oct 2024

New guidance balances GLP-1 risks and benefits for surgery

Most patients may continue to safely take glucagon-like peptide-1 (GLP-1) receptor agonists as prescribed before undergoing elective surgery and gastrointestinal endoscopies, according to new clinical guidance released today by five surgical and medical societies including the American Society for Metabolic and Bariatric Surgery (ASMBS), American Society of Anesthesiologists (ASA), American Gastroenterological Association (AGA), International Society of Perioperative Care of Patients with Obesity (ISPCOP), and Society of American Gastrointestinal and Endoscopic Surgeons (SAGES).

30 Oct 2024

Vitiligo linked to increased risk of heart disease and stroke, study finds

Research indicates elevated cardiovascular risk in vitiligo patients, underscoring the necessity for enhanced monitoring and preventive healthcare measures.

29 Oct 2024

Balance on one leg may be the best indicator of neuromuscular aging, new study suggests

Aging significantly affects unipedal balance and strength, highlighting the need for targeted interventions to address neuromuscular decline in older adults.

29 Oct 2024

Black Americans still suffer worse health. Here’s why there’s so little progress

One morning in late April, a small brick health clinic along the Thurgood Marshall Highway bustled with patients.

28 Oct 2024

Hunger hormone suppressed by intense exercise, study suggests

Research shows high-intensity exercise suppresses appetite by lowering ghrelin levels, with distinct responses observed between male and female participants.

28 Oct 2024

Ozempic effective for patients with chronic kidney damage

In a 24-week trial, semaglutide led to a 52% reduction in albuminuria and improved kidney health in individuals with chronic kidney disease and obesity.

28 Oct 2024

Expanded access to weight-loss drugs could save thousands of lives

Researchers explore the potential benefits of expanding access to novel weight loss drugs to enhance survival rates in overweight and obese individuals.

28 Oct 2024

The importance of muscle preservation in medically induced weight loss

A recent commentary published in The Lancet journal highlights the critical importance of skeletal muscle mass in the context of medically induced weight loss, particularly with the widespread use of GLP-1 receptor agonists.

26 Oct 2024

Diabetes drug semaglutide proves beneficial for patients with chronic kidney damage and obesity

The diabetes drug semaglutide, also known as Ozempic, has a positive effect for patients with chronic kidney damage and obesity. They

26 Oct 2024

Surge in GLP-1 drug use for obesity coincides with drop in bariatric surgery

Researchers from Mass General Brigham and collaborators found that use of GLP-1 drugs to treat obesity more than doubled from 2022 to 2023 while rates of surgery dropped by one quarter.

26 Oct 2024

Semaglutide may reduce Alzheimer's risk in diabetics

Researchers use real-world data in the United States to evaluate the protective role of semaglutide against Alzherimer’s disease.

25 Oct 2024

The hidden effects of opioid use on the endocrine system

A new Scientific Statement released today by the Endocrine Society highlights research gaps associated with the negative effects of opioid use on the endocrine system.

25 Oct 2024

Limiting fast-food outlets can reduce childhood overweight and obesity

Research shows that restricting fast-food outlets can lower obesity rates in children, highlighting the role of planning policies in health outcomes.

25 Oct 2024

Previous
1
...
29
30
31
32
33
34
35
...
1039
Next

Obesity News and Research

Latest Obesity News and Research

Families who ate together more often during the pandemic had more positive interactions

Semaglutide reduces urine albumin-to-creatinine ratio in overweight chronic kidney disease patients

Study links ketogenic diet to improved menstrual health

For kids and teens, extra weight could mean a higher chance of long COVID

Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients

Survey reveals lack of awareness about pancreatic cancer risk among adults under age 50

Higher zinc intake linked to increased endometriosis risk, study finds

New guidance balances GLP-1 risks and benefits for surgery

Vitiligo linked to increased risk of heart disease and stroke, study finds

Balance on one leg may be the best indicator of neuromuscular aging, new study suggests

Black Americans still suffer worse health. Here’s why there’s so little progress

Hunger hormone suppressed by intense exercise, study suggests

Ozempic effective for patients with chronic kidney damage

Expanded access to weight-loss drugs could save thousands of lives

The importance of muscle preservation in medically induced weight loss

Diabetes drug semaglutide proves beneficial for patients with chronic kidney damage and obesity

Surge in GLP-1 drug use for obesity coincides with drop in bariatric surgery

Semaglutide may reduce Alzheimer's risk in diabetics

The hidden effects of opioid use on the endocrine system

Limiting fast-food outlets can reduce childhood overweight and obesity

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Obesity News and Research

Latest Obesity News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in